News / All News / Article

Understand Weiming Penguin’s DIG Digital Intelligence Solutions in One Minute

Article images may contain Chinese text.

In the rapidly changing pharmaceutical industry, data has become a core driver of corporate decision-making and operations. With its innovative DIG digital intelligence solutions, Weiming Penguin is bringing the industry a comprehensive upgrade from digitization to digital intelligence. Today, let’s unveil Weiming Penguin’s DIG solutions together and see how they help companies advance toward digital intelligence.

Image

The D in DIG stands for Data, referring to Weiming Penguin’s robust data foundation. Its automated data collection services cover all mainstream collection methods on the market, enabling fast, accurate data collection. Efficient data cleansing uses intelligent cleansing algorithms based on Weiming Penguin’s patented and AI technologies to deliver accurate, timely data to pharmaceutical companies securely. Over eight years, Weiming Penguin has built industry databases using multiple patents and software copyrights, integrating official data sources such as health commissions and drug regulatory authorities to create an extensive repository of pharmaceutical industry data. These databases help pharmaceutical companies cleanse data efficiently, with more standardized and higher-quality results.

Once a solid underlying data foundation is in place, pharmaceutical companies shift their focus to data applications and insight. Here, insights do not rely solely on a company’s own pharmaceutical distribution data. By integrating the vast amount of data in Weiming Penguin’s industry databases, pharmaceutical companies can gain a clear understanding of market dynamics and their own business, identify potential growth targets, develop corresponding strategies, and uncover potential market opportunities.

The Growth component covers not only master data management but also territory-level performance targets, agreement and policy management, performance target management, and other areas. It gives pharmaceutical companies a visual, analyzable understanding of their data to support business growth. Through big data mining and AI applications, it provides insights into the industry and market, accurately gauges developments at outlets, and gives pharmaceutical companies a basis for decision-making. It provides strong support for pharmaceutical companies’ decisions and establishes a basis for them.

Image

With the arrival of the digital intelligence era, artificial intelligence (AI) applications are gradually reaching every corner of pharmaceutical companies, giving data the ability to sense and making insights smarter. The use of AI technologies not only improves the speed and efficiency of data processing but also fully reveals the value behind the data.
By applying AI in depth to intelligently analyze vast volumes of data, pharmaceutical companies can quickly detect subtle changes in the data. AI gives pharmaceutical companies powerful data-sensing capabilities, deepens business insights, and creates new potential for their development. In the future, as AI technologies continue to advance and find wider application, AI will become an important engine for innovation and growth at pharmaceutical companies.
       Weiming Penguin’s DIG digital intelligence solutions have brought a data revolution to the pharmaceutical industry. With the robust support of DIG and practical applications of AI and other technologies, pharmaceutical companies can achieve data-driven growth and sustainable development. This is the mission of DIG digital intelligence solutions and a continuing driving force behind Weiming Penguin’s future development.

Image